Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Lurbinectedin and Irinotecan in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT)

NCT07328425 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.

NCT NCT07328425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07328425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Lurbinectedin and Irinotecan in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT)
Lead sponsor
Italian Sarcoma Group
Phase
Phase 2
Overall status
Recruiting
Start date
November 21, 2025
Completion date
October 1, 2030
Enrollment
20 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

desmoplastic small round cell tumor